Cargando…
Narciclasine inhibits phospholipase A2 and regulates phospholipid metabolism to ameliorate psoriasis-like dermatitis
INTRODUCTION: Psoriasis is a common inflammatory skin disease recognized by the World Health Organization as "an incurable chronic, noninfectious, painful, disfiguring and disabling disease." The fact that metabolic syndrome (MetS) is the most common and important comorbidities of psoriasi...
Autores principales: | Kong, Yi, Jiang, Jian, Huang, Yuqiong, Liu, Xin, Jin, Zilin, Li, Li, Wei, Fen, Liu, Xinxin, Yin, Jie, Zhang, Yonghui, Tong, Qingyi, Chen, Hongxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869703/ https://www.ncbi.nlm.nih.gov/pubmed/36700214 http://dx.doi.org/10.3389/fimmu.2022.1094375 |
Ejemplares similares
-
Narciclasine attenuates sepsis-induced myocardial injury by modulating autophagy
por: Tang, Rong, et al.
Publicado: (2021) -
Conversion of Natural Narciclasine to Its C-1 and C-6 Derivatives and Their Antitumor Activity Evaluation: Some Unusual Chemistry of Narciclasine †
por: Goulart Stollmaier, Juana, et al.
Publicado: (2022) -
Amelioration of imiquimod-induced psoriasis-like dermatitis in mice by DSW therapy inspired hydrogel
por: He, Xiang, et al.
Publicado: (2020) -
Lipoxin A4 Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis via Promoting the Regression of Inflammation
por: Hu, Feng, et al.
Publicado: (2023) -
Applications of single-cell RNA sequencing in atopic dermatitis and psoriasis
por: Xia, Dengmei, et al.
Publicado: (2022)